Frontotemporal lobar degeneration.
Grossman M, Seeley WW, Boxer AL, Hillis AE, Knopman DS, Ljubenov PA, Miller B, Piguet O, Rademakers R, Whitwell JL, Zetterberg H, van Swieten JC.
Nat Rev Dis Primers. 2023 Aug 10;9(1):40. doi: 10.1038/s41572-023-00447-0.
HnRNP Pathologies in Frontotemporal Lobar Degeneration.
Jiang X, Gatt A, Lashley T.
Cells. 2023 Jun 15;12(12):1633. doi: 10.3390/cells12121633.
Frontotemporal Lobar Degeneration.
Premi E, Padovani A, Borroni B.
Adv Exp Med Biol. 2012;724:114-27. doi: 10.1007/978-1-4614-0653-2_9.
Immunological signatures in frontotemporal lobar degeneration.
Sirkis DW, Bonham LW, Karch CM, Yokoyama JS.
Curr Opin Neurol. 2019 Apr;32(2):272-278. doi: 10.1097/WCO.0000000000000665.
Review: Neuropathology of non-tau frontotemporal lobar degeneration.
Neumann M, Mackenzie IRA.
Neuropathol Appl Neurobiol. 2019 Feb;45(1):19-40. doi: 10.1111/nan.12526.
Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.
Carlos AF, Josephs KA.
J Neurol. 2022 Aug;269(8):4030-4054. doi: 10.1007/s00415-022-11073-3. Epub 2022 Mar 23.
Neurotransmitter deficits from frontotemporal lobar degeneration.
Murley AG, Rowe JB.
Brain. 2018 May 1;141(5):1263-1285. doi: 10.1093/brain/awx327.
Neuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility.
Dev SI, Dickerson BC, Touroutoglou A.
Adv Exp Med Biol. 2021;1281:93-112. doi: 10.1007/978-3-030-51140-1_7.
Imaging frontotemporal lobar degeneration.
Diehl-Schmid J, Onur OA, Kuhn J, Gruppe T, Drzezga A.
Curr Neurol Neurosci Rep. 2014 Oct;14(10):489. doi: 10.1007/s11910-014-0489-x.
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations.
Boeve BF, Boxer AL, Kumfor F, Pijnenburg Y, Rohrer JD.
Lancet Neurol. 2022 Mar;21(3):258-272. doi: 10.1016/S1474-4422(21)00341-0.
